Arizona State Retirement System Sells Shares of Embecta Corp.
November 10, 2023
☀️Trending News
The Arizona State Retirement System has recently sold shares of Embecta Corp ($NASDAQ:EMBC). Embecta Corp is a leading technology company that focuses on providing innovative solutions for businesses and organizations from around the world. With their advanced technology, Embecta has become a leader in the industry and continues to develop cutting-edge products and services. The Arizona State Retirement System’s decision to sell its shares of Embecta Corp is likely due to the company’s current market value and performance.
Embecta’s stock has seen fluctuating prices over the last few years, but the company has done its best to ensure that their stock prices remain stable for investors. This strategy has paid off, as investors have seen steady returns from their investment in Embecta Corp. The company is known for its innovative solutions and continues to push boundaries in the technology space. With their forward-thinking approach and dedication to providing quality products and services, Embecta will continue to be a major player in the tech industry.
Stock Price
On Thursday, Arizona State Retirement System announced the sale of part of their shareholding in EMBECTA CORP. The stock opened at $15.5 and closed at $14.7, falling by 4.4% from its previous closing price of 15.4. This decision to sell shares signals a shift in the Arizona State Retirement System’s investment approach, as they look to diversify their portfolio and reduce exposure to the technology sector. The sale of EMBECTA CORP shares is a reminder of the volatility of the stock market, and investors should remain vigilant when making investments. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Embecta Corp. More…
| Total Revenues | Net Income | Net Margin |
| 1.11k | 47.2 | 7.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Embecta Corp. More…
| Operations | Investing | Financing |
| 96.1 | -25.9 | -46.1 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Embecta Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.25k | 2.06k | -14.13 |
Key Ratios Snapshot
Some of the financial key ratios for Embecta Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 0.6% | -9.8% | 15.7% |
| FCF Margin | ROE | ROA |
| 6.3% | -13.4% | 8.7% |
Analysis
As GoodWhale, we have analyzed the financials of EMBECTA CORP and identified it as a ‘cow’ type of company which has a track record of paying out consistent and sustainable dividends. This type of company is likely to attract value investors who are looking for long-term yield. An analysis of EMBECTA CORP’s performance according to Star Chart reveals that the company is strong in assets, medium in dividend, profitability and weak in growth. However, its health score of 8/10, considering its cashflows and debt, is indicative of its capability to sustain future operations even in times of crisis. More…
Peers
The company was founded in 1980 and is headquartered in New York, NY. Embecta Corp‘s products include prescription drugs for the treatment of cardiovascular disease, diabetes, and cancer. The company’s competitors include Uluru Inc, RxSight Inc, and Modalis Therapeutics Corp.
– Uluru Inc ($OTCPK:ULUR)
RxSight Inc is a medical device company that develops and commercializes innovative ophthalmic implants that allow ophthalmologists to more precisely treat complex retinal diseases. As of 2022, the company has a market capitalization of 318.4 million and a return on equity of -31.3%.
– RxSight Inc ($NASDAQ:RXST)
Modalis Therapeutics Corp is a biopharmaceutical company that focuses on the development of therapeutics for the treatment of cancer and other diseases. The company has a market cap of 11.21B as of 2022 and a return on equity of -13.14%. Modalis Therapeutics Corp is headquartered in New York, New York.
Summary
EMBECTA CORP is a publicly listed company with shares traded on the stock market. Recently, the Arizona State Retirement System sold a large amount of EMBECTA CORP shares, causing the stock price to decline on that day. Although the share price has been volatile in the past, analysts are watching to see if this large sale will have a more significant impact on the stock. For investors looking to buy into EMBECTA CORP, it is important to examine the company’s fundamentals and financials.
Analysing the company’s balance sheet, income statement, cash flow statement and other financials can provide insights into the company’s performance and potential investability. Analysts also recommend researching and considering market trends to better understand the potential return on investment.
Related Posts
Recent Posts
